This health news roundup covers significant advances and alerts, including the approval of Bristol Myers' new schizophrenia ...
The FDA has approved Cobenfy, the first new schizophrenia treatment in 30 years, offering a novel approach with fewer side effects. Developed by Karuna Therapeutics, the drug is set to provide new ...
The Food and Drug Administration on Thursday approved the first novel antipsychotic treatment in decades, a drug developed to ...